Parameter | All patients | Insulin naïve | Insulin users |
N (%) | 509 (100) | 392 (77) | 117 (23) |
Gender (male/female) | 53.6/46.4 | 55.6/44.4 | 47.0/53.0 |
Age*, years | 55.8 (10.9) | 55.7 (10.3) | 56.0 (12.8) |
Body weight*, kg | 82.2 (15.9) | 81.3 (15.7) | 84.8 (16.5) |
Body mass index*, kg/m2 | 28.8 (5.2) | 28.3 (4.9) | 30.4 (5.9) |
Duration of diabetes*, years | 9.4 (5.1) | 9.0 (4.8) | 10.7 (5.7) |
Time to insulin initiation*, years | 8.7 (4.9) | 9.1 (4.9) | 7.6 (4.9) |
Duration on OGLDs*, years | 8.9 (4.7) | 8.9 (4.6) | 8.9 (5.0) |
Duration on insulin*, years | 1.0 (2.6) | 0.3 (1.6)† | 3.3 (3.7) |
HbA1c*, % | 9.8 (1.4) | 9.9 (1.3) | 9.1 (1.4) |
OGLDs, n (%) | |||
Metformin | 338 (98.0) | 279 (97.6) | 59 (100) |
Sulfonylurea | 66 (19.1) | 62 (21.7) | 4 (6.8) |
Thiazolidinediones | 20 (5.8) | 20 (7.0) | 0 (0) |
One Two >Two | 269 (78.0) 57 (16.5) 19 (5.5) | 214 (74.8) 53 (18.5) 19 (6.6) | 55 (93.2) 4 (6.8) 0 (0) |